Novartis (NYSE:NVS)


Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Stocks bounced on Thursday, but Friday's early trading indications were looking for a sharp sell-off of almost 2%, based on more oil and China weakness. This is also ahead of ...
Read Full Story »

4 Stocks to Help You Sleep Easy as Market Falls

Markets look set for their worst two-day opening performance since 1932. If that makes you nervous for the rest of what 2016 has to offer, you’re not alone. Before panicking ...
Read Full Story »
Medicine pills

Jefferies Top Pharma Stock Picks for 2016

Although most pharmaceutical stocks might trade down in the market Monday afternoon, most investors are looking past just the day and at what these stocks can do in the future. In ...
Read Full Story »
generic drugs

FDA Grants Expanded Use of Promacta for Novartis

Novartis AG (NYSE: NVS) is one of the few companies with good news on a major market sell-off. Unfortunately, it is not big enough news to be moving the shares. ...
Read Full Story »
investor research

Is AVEO the Next Aquinox for Traders?

AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) made waves in early trading indications Monday on news of a licensing agreement with Novartis A.G. (NYSE: NVS). Both companies announced an exclusive, worldwide license ...
Read Full Story »
Comfortable hospital bed

Will Biogen Win From Novartis MS Drug Safety Label Change?

There are times when a negative piece of news in the BioPharma sector can actually help rival companies. Biogen Inc. (NASDAQ: BIIB) is a stock that has been battered of ...
Read Full Story »

Meet the Next Mega Blockbuster Heart Drug

Novartis A.G. (NYSE: NVS) is getting ready to steal a lot of hearts with its newest drug. The FDA has approved Entresto tablets, known as LCZ696, for the treatment of heart failure ...
Read Full Story »

5 Dividend Stocks to Buy as European Index Crushes S&P 500

After years of underperformance, the STOXX Europe 600 is mauling the S&P 500 this year, and it is a trend that could continue for a while. The large European index ...
Read Full Story »

Analyst’s 8 Top Health Care Stocks for 2015

Health care had an outstanding year in 2014. In fact the sector through last Friday was up 23.30%, which placed it third in the S&P 500 sector race, just behind ...
Read Full Story »

Is a Generic Diovan for You?

Many investors have to worry about the so-called patent cliff in pharmaceutical companies. Generic launches are often priced into most analyst estimates, but these generic launches are always important to ...
Read Full Story »

Array BioPharma: When Losing a Partnership Is Good News

Array BioPharma Inc. (NASDAQ: ARRY) announced Wednesday after the market close that it had reached a definitive agreement with Novartis A.G. (NYSE: NVS) to regain full worldwide rights to cancer ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AEP, BP, Halliburton, Cypress Semi, J.C. Penney, Schlumberger, SanDisk and More

Stocks were looking for direction Wednesday morning. Investors keep proving that they will buy value stocks or stocks that are discounted when they can. 24/7 Wall St. looks over dozens ...
Read Full Story »
Shell sign at dusk

J.P. Morgan’s 5 Top International Stock Picks

While the U.S. markets have absolutely been on fire, the terminally slow-growth European bourses have been miserable this year for the most part, lagging domestic markets by 22% in U.S. ...
Read Full Story »
Volkswagen Golf 2015

Companies Spending the Most on R&D

For the third consecutive year, the company spending the most on research and development (R&D) was Germany’s Volkswagen. The automaker’s 2014 R&D spending will total $13.5 billion, just ahead of ...
Read Full Story »

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

One sad thing for almost every citizen in the United States is that at one point almost all of us will either have cancer or have a friend or relative ...
Read Full Story »